jnj-73763989
Showing 1 - 8 of 8
Renal Impairment Trial in Kiel (JNJ-73763989)
Recruiting
- Renal Impairment
- JNJ-73763989
-
Kiel, GermanyCRS Clinical Research Services Kiel GmbH
Aug 2, 2022
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)
Active, not recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Edegem, Belgium
- +12 more
Jan 17, 2023
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)
Terminated
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Hillsborough, New Jersey
- +11 more
Dec 28, 2022
Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))
Active, not recruiting
- Hepatitis B
- JNJ-73763989
- +5 more
-
Baltimore, Maryland
- +9 more
Jan 17, 2023
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)
Recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Vancouver, British Columbia, Canada
- +31 more
Jan 17, 2023
Hepatitis D, Chronic Trial in Worldwide (JNJ-73763989, Placebo, Entecavir (ETV) monohydrate)
Active, not recruiting
- Hepatitis D, Chronic
- JNJ-73763989
- +4 more
-
Redwood City, California
- +68 more
Jan 17, 2023
Healthy Trial in Beijing (JNJ-73763989)
Completed
- Healthy
- JNJ-73763989
-
Beijing, ChinaPeking University Third Hospital
Mar 4, 2021
Hepatic Impairment Trial in Kiel (JNJ-73763989)
Completed
- Hepatic Impairment
- JNJ-73763989
-
Kiel, GermanyCRS Clinical Research Services Kiel GmbH
Sep 29, 2020